PATHOLOGY ASIA HOLDINGS
Pathology Asia Holdings is a medical diagnostics company that is self-contained. According to Pathology Asia, it takes a doctor to know a doctor. As a result, both doctors and corporate professionals are in charge of our medical care. Their goal is to make quality diagnostic services available to people all around Southeast Asia and beyond.
PATHOLOGY ASIA HOLDINGS
Social Links:
Industry:
Health Care Health Diagnostics Medical Wellness
Founded:
2018-01-01
Status:
Active
Email Addresses:
[email protected]
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-12 | Bluestar Genomics | Pathology Asia Holdings investment in Series C - Bluestar Genomics | 70 M USD |
More informations about "Pathology Asia Holdings" on Search Engine
About Us • Pathology Asia
With leading medical diagnostic laboratories in Singapore, Malaysia, Vietnam, the Philippines, Indonesia and Australia; as well as a digital platform for healthcare providers, Pathology Asia aspires to be the foremost trusted diagnostics services provider in Southeast Asia and Australasia.See details»
Group • Pathology Asia
Pathology Asia is headquartered in Singapore with a presence in Southeast Asia and Australia. Our laboratories include Innoquest Diagnostics, one of the largest diagnostic service providers in Singapore; Innoquest Pathology (formerly Gribbles Pathology), a market leader in Malaysia; and Safework Health, a leading occupational health provider ...See details»
Pathology Asia
FOR DOCTORS. Pathology Asia believes it takes a doctor to know a doctor. That's why we are medically managed with doctors at the centre of decision making. Our mission is to make high quality diagnostic services accessible and affordable throughout Southeast Asia’s c.680 million population.See details»
Dr. Christopher Ting – Imagene Labs
Dr. Christopher Ting is the Group CEO & Founder of Pathology Asia Holdings. He was previously responsible for heading Healthscope’s pathology interest in South East Asia.See details»
Pathology Asia Holdings Pte Ltd - Company Profile and …
Pathology Asia Holdings Pte. Ltd. operates as an investment holding company. The Company serves customers in Singapore. Israeli Airstrike, Egyptian Guard’s Death Ratchet Up Tensions. 3 hours...See details»
Pathology Asia | LinkedIn
About us. At Pathology Asia, we understand how critical a medical lab result can be for you. We are one of you, whether you're a patient, a doctor, or a loved one. Our goal is to provide...See details»
TPG closes in on Pathology Asia stake sale | PitchBook
Jan 20, 2022 TPG Asia is nearing the sale of a minority stake in Pathology Asia Holdings in a deal that would value the healthcare specialist at around $2 billion, Bloomberg reported. Government-backed investors from the Middle East and Asia are among those interested in buying the stake. View details. Share: . . . . Tags: Private Equity.See details»
Pathology Asia Company Profile 2024: Valuation, …
Description. Provider of clinical diagnostic services supports decision-making to offer the best patient outcomes. The company offers diagnostic services, alcohol and other drugs (AOD) advisory services, clinical-grade genetic testing and genomics services for translational research, thereby ensuring quality and affordable diagnostics to patients.See details»
About Us • Innoquest Diagnostics
Pathology Asia Holdings (PAH), as part of TPG Capital Asia – a leading global private investment firm– acquired both IDPL and Quest in September 2018. After a year of planning and restructuring, we started our journey to merge the 2 entities into one and thus forming Innoquest Diagnostics Pte Ltd.See details»
TPG Said to Near Pathology Asia Stake Sale at $2 …
Jan 19, 2022 (Bloomberg) -- Private equity firm TPG Capital Asia is close to an agreement to sell a minority stake in Pathology Asia Holdings Pte in a deal that values the health-care business at about $2 billion, according to people with knowledge of the matter.See details»
TPG Chooses Banks for $594 Million Asian Pathology IPO
Mar 26, 2021 Pathology Asia Holdings, originally formed out of the Healthscope purchase, includes the Quest Laboratories brand in Singapore and Vietnam, and Gribbles Pathology in Malaysia.See details»
TPG Said to Near Pathology Asia Stake Sale at $2 Billion Value
Jan 19, 2022 By Elffie Chew and Manuel Baigorri. January 19, 2022 at 4:02 AM EST. This article is for subscribers only. Private equity firm TPG Capital Asia is close to an agreement to sell a minority stake...See details»
TPG chooses banks for $800 mil IPO of its Pathology Asia Holdings
Mar 26, 2021 Pathology Asia Holdings, originally formed out of the Healthscope purchase, includes the Quest Laboratories brand in Singapore and Vietnam, and Gribbles Pathology in Malaysia.See details»
TPG Weighing Pathology Asia Stake Sale Ahead of IPO
December 7, 2021 at 7:41 PM PST. Listen. 1:46. This article is for subscribers only. Private equity firm TPG Capital Asia is exploring selling a stake in its pathology business in the region...See details»
Management Team • Pathology Asia
Management Team. DR. CHRISTOPHER TING. Executive Vice Chairman. Co-Group CEO. Executive Director, PAH (Australia) Co-founder of Pathology Asia. Co-founder of Biomark. Former CEO of Innovative Diagnostics.See details»
TPG's Asian arm mulls listing for Pathology Asia – Bloomberg
Mar 4, 2021 Author Pam Rosacia. Theme Healthcare & Pharmaceuticals Banking. TPG Capital LP's Asian arm is exploring a potential IPO for Singapore-based Pathology Asia Holdings Pte. Ltd. and has sought proposals from banks for the plan, Bloomberg News reported, citing people with knowledge of the matter.See details»
Pathology Asia Holdings - CB Insights
Jun 1, 2004 Submit portfolio details. Latest Pathology Asia Holdings News. Learn more by joining our daily demo. Pathology Asia Holdings Investments. 1 Investments. Pathology Asia Holdings has made 1 investments. Their latest investment was in Bluestar Genomics as part of their Series C on May 12, 2021. Pathology Asia Holdings …See details»
Team & Culture
Christopher Ting. Group CEO - Pathology Asia. He is currently the CEO of Pathology Asia Holdings (Singapore), the largest network of laboratories in Southeast Asia... Read Full Bio. Ritche D. Evidente. President & CEO. Under his leadership, he has grown SGD into one of the largest reference laboratories in the Philippines... Read Full Bio.See details»
Pathology Asia Holdings - Contacts, Employees, Board …
About. Pathology Asia Holdings has 1 current employee profile, Founder & CEO Christopher Ting. Contacts. Job Department. Protected Content. National Quality Manager. Manager Management. 1 email found. View. Protected Content. Senior Consultant : Genomics. Non-Management Pro Services. 1 email found. View. Showing 2 of 2. …See details»
Pathology Asia Holdings Pte. Ltd. in Singapore, Asia - SWFI
Dec 1, 2021 Pathology Asia Holdings Pte. Ltd. (located in Singapore, Asia) was purchased by a Sovereign Wealth Fund from Malaysia on 12/01/2021 as a Deal in the Healthcare Providers and Services industry. ... (SWFI) is a global organization designed to study sovereign wealth funds, pensions, endowments, superannuation funds, family …See details»